Xenetic Bio (XBIO) - Rasio bathi reged

Lambang korporat lan logo Xenetic Biosciences (XBIO)

Xenetic Biosciences (XBIO) gross margin as a percentage of revenue reflects the impact of licensing DNase technologies to oncology centers, with the 0.00 level serving as a critical benchmark. Stability in these metrics is supported by streamlined collaboration with contract laboratories during drug development. High efficiency is achieved through a strategic focus on R&D and the collection of royalties from pharma behemoths, which completely eliminates manufacturing costs.

XBIO Margin reged Xenetic Bio (04.07.2022 - 20.11.2026)

Rincian metrik keuangan lan pasar Xenetic Biosciences Inc. (XBIO)

- nilai saham lan prakiraan konsensus rega:
- rincian posisi dhuwit lan arus kas:
Pambiji fundamental:XBIO - xeneticbio.com
Produk sing diprodhuksi Xenetic Biosciences, Inc.

For Xenetic Biosciences (XBIO), which is developing an oncology ecosystem based on DNase, gross margin serves as an indicator of innovation monetization efficiency. This metric is calculated as the share of revenue minus direct production costs, allowing for an assessment of the fundamental profitability of each therapy unit. By analyzing gross profitability trends, an investor can determine how successfully the company's technological advantage is converted into operating profit.

Pesaing utama

Margin bathi reged BeiGene Ltd. (ONC)|Tingkat bathi miturut bathi reged HALO|Rentabilitas reged RVMD|Tingkat bathi miturut bathi reged AAPG (Ascentage)|Tingkat bathi miturut bathi reged cgoncology.com CGON|UroGen Pharma - Tingkat bathi miturut bathi reged|Tingkat bathi reged BCAX|PSNL - Rentabilitas reged|Rentabilitas dodolan miturut bathi reged Erasca Oncology ERAS|delcath.com (DCTH) - Rentabilitas reged|Y-mAbs Therapeutics - Tingkat bathi reged|AURA (Aura Biosciences Inc) - Margin reged|Margin bathi reged candeltx.com CADL|Margin reged ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Tingkat bathi reged|Rentabilitas reged Actuate Therapeutics, Inc. ACTU|citiusonc.com - Rentabilitas reged|TuHURA Biosciences Inc. - Margin reged|TARA - Margin reged|FATE (Fate Therapeutics) - Tingkat bathi miturut bathi reged|Tingkat bathi miturut bathi reged Aadi Bioscience, Inc.|Tingkat bathi miturut bathi reged TCRX|Rentabilitas reged CSBR|Margin reged XBIT|Rentabilitas dodolan miturut bathi reged CEL-SCI Corp.|Rentabilitas reged ostherapies.com OSTX|RADX: Rentabilitas dodolan reged|ARTV: Tingkat bathi miturut bathi reged|ANL (Adlai Nortye) - Rentabilitas dodolan reged|Veru (VERU) - Rentabilitas reged|Tingkat bathi miturut bathi reged Tempest Therapeutics Inc|Rentabilitas reged Xilio Therapeutics|Rentabilitas dodolan reged RENB (Renovaro Inc.)|Rentabilitas reged Mural Oncology PLC (MURA)|Margin reged Kairos Pharma (KAPA)|Rentabilitas reged onkuretherapeutics.com OKUR|GDTC: Rentabilitas dodolan reged|CRIS: Tingkat bathi miturut bathi reged|apollomicsinc.com (APLM) - Tingkat bathi miturut bathi reged|THAR: Margin reged|Tingkat bathi miturut bathi reged Advanced Biomed Inc.|Tingkat bathi miturut bathi reged GNPX|Rentabilitas dodolan reged CLDI (Calidi Biotherapeutics)|Margin reged SBFM|Rentabilitas reged SLRX (Salarius Pharma)|Kitov Pharma - Tingkat bathi miturut bathi reged|American Oncology Network (AONC) - Margin bathi reged|BeiGene - Margin reged|Checkpoint Therapeutics, Inc. (CKPT) - Tingkat bathi miturut bathi reged|ELEV (Elevation Oncology, Inc.) - Tingkat bathi miturut bathi reged|iCAD Inc. - Tingkat bathi reged|Tingkat bathi miturut bathi reged IKNA|Margin reged notablelabs.com|Tingkat bathi miturut bathi reged VIRX (Viracta Therapeutics Inc.)|MOR - Margin bathi reged|Rentabilitas reged NAYA Biosciences NAYA|AAPGV - Tingkat bathi miturut bathi reged